TRANSL LUNG CANCER R 润色咨询

Translational Lung Cancer Research

出版年份：暂无数据 年文章数：1359 投稿命中率： 开通期刊会员，数据随心看

出版周期：暂无数据 自引率：暂无数据 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2271609, encodeId=b77822e1609c1, content=11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60209766606, createdName=ms1000000753909589, createdTime=Tue Jul 01 15:19:43 CST 2025, time=2025-07-01, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1219217, encodeId=9458121921e5d, content=想问一下，这个回复审稿人意见是在网站提交还是回复邮件呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60115590202, createdName=Sci中中中中中中, createdTime=Thu May 12 23:55:19 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2224846, encodeId=19a72224846e1, content=审稿速度:6.0 | 投稿命中率:75.0<br>偏重的研究方向：III期研究;肺癌;protocol<br>经验分享：III期研究的protocol还是容易接收，毕竟可能会带动引用率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220704/1acf1fcc54b540239da4b101eb02ebc4/379539e2ee554698a231b4f45583be89.jpg, createdBy=62942283774, createdName=海参饲养员, createdTime=Mon Sep 09 15:41:35 CST 2024, time=2024-09-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=921523, encodeId=75b8921523d0, content=投稿命中率:50.0<br>经验分享：投稿到接受4个月，接受到见刊2个月。着急的的还是绕道吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200708/e0c0acd4c1714a6e8a657fd5e53d76a4/ab7ebd1a6ae24cbdb95ceb66dff657b5.jpg, createdBy=3dad2459355, createdName=Lambda.w, createdTime=Sat Jan 30 23:41:55 CST 2021, time=2021-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1112948, encodeId=3ae41112948cb, content=摘要一定要描述使用的方法么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:54 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1112947, encodeId=548b111294e83, content=摘要和HIGHLIGHTS的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:54 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917956, encodeId=57b391e9569c, content=这个杂志都没人投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7ad5420475, createdName=ms9000000350038058, createdTime=Tue Jan 19 09:06:30 CST 2021, time=2021-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575742, encodeId=8e405e57422e, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享：一审半年意见中肯接受后1月出proof见刊超快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a83b1569848, createdName=36410008, createdTime=Mon Sep 02 21:06:00 CST 2019, time=2019-09-02, status=1, ipAttribution=)]
    2025-07-01 ms1000000753909589 来自江西省

    11

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2271609, encodeId=b77822e1609c1, content=11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60209766606, createdName=ms1000000753909589, createdTime=Tue Jul 01 15:19:43 CST 2025, time=2025-07-01, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1219217, encodeId=9458121921e5d, content=想问一下，这个回复审稿人意见是在网站提交还是回复邮件呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60115590202, createdName=Sci中中中中中中, createdTime=Thu May 12 23:55:19 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2224846, encodeId=19a72224846e1, content=审稿速度:6.0 | 投稿命中率:75.0<br>偏重的研究方向：III期研究;肺癌;protocol<br>经验分享：III期研究的protocol还是容易接收，毕竟可能会带动引用率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220704/1acf1fcc54b540239da4b101eb02ebc4/379539e2ee554698a231b4f45583be89.jpg, createdBy=62942283774, createdName=海参饲养员, createdTime=Mon Sep 09 15:41:35 CST 2024, time=2024-09-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=921523, encodeId=75b8921523d0, content=投稿命中率:50.0<br>经验分享：投稿到接受4个月，接受到见刊2个月。着急的的还是绕道吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200708/e0c0acd4c1714a6e8a657fd5e53d76a4/ab7ebd1a6ae24cbdb95ceb66dff657b5.jpg, createdBy=3dad2459355, createdName=Lambda.w, createdTime=Sat Jan 30 23:41:55 CST 2021, time=2021-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1112948, encodeId=3ae41112948cb, content=摘要一定要描述使用的方法么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:54 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1112947, encodeId=548b111294e83, content=摘要和HIGHLIGHTS的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:54 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917956, encodeId=57b391e9569c, content=这个杂志都没人投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7ad5420475, createdName=ms9000000350038058, createdTime=Tue Jan 19 09:06:30 CST 2021, time=2021-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575742, encodeId=8e405e57422e, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享：一审半年意见中肯接受后1月出proof见刊超快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a83b1569848, createdName=36410008, createdTime=Mon Sep 02 21:06:00 CST 2019, time=2019-09-02, status=1, ipAttribution=)]
    2022-05-12 Sci中中中中中中

    想问一下，这个回复审稿人意见是在网站提交还是回复邮件呢？

    4

    展开4条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2271609, encodeId=b77822e1609c1, content=11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60209766606, createdName=ms1000000753909589, createdTime=Tue Jul 01 15:19:43 CST 2025, time=2025-07-01, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1219217, encodeId=9458121921e5d, content=想问一下，这个回复审稿人意见是在网站提交还是回复邮件呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60115590202, createdName=Sci中中中中中中, createdTime=Thu May 12 23:55:19 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2224846, encodeId=19a72224846e1, content=审稿速度:6.0 | 投稿命中率:75.0<br>偏重的研究方向：III期研究;肺癌;protocol<br>经验分享：III期研究的protocol还是容易接收，毕竟可能会带动引用率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220704/1acf1fcc54b540239da4b101eb02ebc4/379539e2ee554698a231b4f45583be89.jpg, createdBy=62942283774, createdName=海参饲养员, createdTime=Mon Sep 09 15:41:35 CST 2024, time=2024-09-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=921523, encodeId=75b8921523d0, content=投稿命中率:50.0<br>经验分享：投稿到接受4个月，接受到见刊2个月。着急的的还是绕道吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200708/e0c0acd4c1714a6e8a657fd5e53d76a4/ab7ebd1a6ae24cbdb95ceb66dff657b5.jpg, createdBy=3dad2459355, createdName=Lambda.w, createdTime=Sat Jan 30 23:41:55 CST 2021, time=2021-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1112948, encodeId=3ae41112948cb, content=摘要一定要描述使用的方法么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:54 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1112947, encodeId=548b111294e83, content=摘要和HIGHLIGHTS的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:54 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917956, encodeId=57b391e9569c, content=这个杂志都没人投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7ad5420475, createdName=ms9000000350038058, createdTime=Tue Jan 19 09:06:30 CST 2021, time=2021-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575742, encodeId=8e405e57422e, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享：一审半年意见中肯接受后1月出proof见刊超快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a83b1569848, createdName=36410008, createdTime=Mon Sep 02 21:06:00 CST 2019, time=2019-09-02, status=1, ipAttribution=)]
    2024-09-09 海参饲养员 来自广东省

    审稿速度:6.0 | 投稿命中率:75.0
    偏重的研究方向：III期研究;肺癌;protocol
    经验分享：III期研究的protocol还是容易接收，毕竟可能会带动引用率

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2271609, encodeId=b77822e1609c1, content=11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60209766606, createdName=ms1000000753909589, createdTime=Tue Jul 01 15:19:43 CST 2025, time=2025-07-01, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1219217, encodeId=9458121921e5d, content=想问一下，这个回复审稿人意见是在网站提交还是回复邮件呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60115590202, createdName=Sci中中中中中中, createdTime=Thu May 12 23:55:19 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2224846, encodeId=19a72224846e1, content=审稿速度:6.0 | 投稿命中率:75.0<br>偏重的研究方向：III期研究;肺癌;protocol<br>经验分享：III期研究的protocol还是容易接收，毕竟可能会带动引用率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220704/1acf1fcc54b540239da4b101eb02ebc4/379539e2ee554698a231b4f45583be89.jpg, createdBy=62942283774, createdName=海参饲养员, createdTime=Mon Sep 09 15:41:35 CST 2024, time=2024-09-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=921523, encodeId=75b8921523d0, content=投稿命中率:50.0<br>经验分享：投稿到接受4个月，接受到见刊2个月。着急的的还是绕道吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200708/e0c0acd4c1714a6e8a657fd5e53d76a4/ab7ebd1a6ae24cbdb95ceb66dff657b5.jpg, createdBy=3dad2459355, createdName=Lambda.w, createdTime=Sat Jan 30 23:41:55 CST 2021, time=2021-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1112948, encodeId=3ae41112948cb, content=摘要一定要描述使用的方法么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:54 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1112947, encodeId=548b111294e83, content=摘要和HIGHLIGHTS的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:54 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917956, encodeId=57b391e9569c, content=这个杂志都没人投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7ad5420475, createdName=ms9000000350038058, createdTime=Tue Jan 19 09:06:30 CST 2021, time=2021-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575742, encodeId=8e405e57422e, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享：一审半年意见中肯接受后1月出proof见刊超快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a83b1569848, createdName=36410008, createdTime=Mon Sep 02 21:06:00 CST 2019, time=2019-09-02, status=1, ipAttribution=)]
    2021-01-30 Lambda.w

    投稿命中率:50.0
    经验分享：投稿到接受4个月，接受到见刊2个月。着急的的还是绕道吧。

    5

    展开5条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2271609, encodeId=b77822e1609c1, content=11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60209766606, createdName=ms1000000753909589, createdTime=Tue Jul 01 15:19:43 CST 2025, time=2025-07-01, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1219217, encodeId=9458121921e5d, content=想问一下，这个回复审稿人意见是在网站提交还是回复邮件呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60115590202, createdName=Sci中中中中中中, createdTime=Thu May 12 23:55:19 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2224846, encodeId=19a72224846e1, content=审稿速度:6.0 | 投稿命中率:75.0<br>偏重的研究方向：III期研究;肺癌;protocol<br>经验分享：III期研究的protocol还是容易接收，毕竟可能会带动引用率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220704/1acf1fcc54b540239da4b101eb02ebc4/379539e2ee554698a231b4f45583be89.jpg, createdBy=62942283774, createdName=海参饲养员, createdTime=Mon Sep 09 15:41:35 CST 2024, time=2024-09-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=921523, encodeId=75b8921523d0, content=投稿命中率:50.0<br>经验分享：投稿到接受4个月，接受到见刊2个月。着急的的还是绕道吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200708/e0c0acd4c1714a6e8a657fd5e53d76a4/ab7ebd1a6ae24cbdb95ceb66dff657b5.jpg, createdBy=3dad2459355, createdName=Lambda.w, createdTime=Sat Jan 30 23:41:55 CST 2021, time=2021-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1112948, encodeId=3ae41112948cb, content=摘要一定要描述使用的方法么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:54 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1112947, encodeId=548b111294e83, content=摘要和HIGHLIGHTS的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:54 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917956, encodeId=57b391e9569c, content=这个杂志都没人投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7ad5420475, createdName=ms9000000350038058, createdTime=Tue Jan 19 09:06:30 CST 2021, time=2021-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575742, encodeId=8e405e57422e, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享：一审半年意见中肯接受后1月出proof见刊超快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a83b1569848, createdName=36410008, createdTime=Mon Sep 02 21:06:00 CST 2019, time=2019-09-02, status=1, ipAttribution=)]
    2021-12-29 rayms

    摘要一定要描述使用的方法么？

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2271609, encodeId=b77822e1609c1, content=11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60209766606, createdName=ms1000000753909589, createdTime=Tue Jul 01 15:19:43 CST 2025, time=2025-07-01, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1219217, encodeId=9458121921e5d, content=想问一下，这个回复审稿人意见是在网站提交还是回复邮件呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60115590202, createdName=Sci中中中中中中, createdTime=Thu May 12 23:55:19 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2224846, encodeId=19a72224846e1, content=审稿速度:6.0 | 投稿命中率:75.0<br>偏重的研究方向：III期研究;肺癌;protocol<br>经验分享：III期研究的protocol还是容易接收，毕竟可能会带动引用率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220704/1acf1fcc54b540239da4b101eb02ebc4/379539e2ee554698a231b4f45583be89.jpg, createdBy=62942283774, createdName=海参饲养员, createdTime=Mon Sep 09 15:41:35 CST 2024, time=2024-09-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=921523, encodeId=75b8921523d0, content=投稿命中率:50.0<br>经验分享：投稿到接受4个月，接受到见刊2个月。着急的的还是绕道吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200708/e0c0acd4c1714a6e8a657fd5e53d76a4/ab7ebd1a6ae24cbdb95ceb66dff657b5.jpg, createdBy=3dad2459355, createdName=Lambda.w, createdTime=Sat Jan 30 23:41:55 CST 2021, time=2021-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1112948, encodeId=3ae41112948cb, content=摘要一定要描述使用的方法么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:54 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1112947, encodeId=548b111294e83, content=摘要和HIGHLIGHTS的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:54 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917956, encodeId=57b391e9569c, content=这个杂志都没人投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7ad5420475, createdName=ms9000000350038058, createdTime=Tue Jan 19 09:06:30 CST 2021, time=2021-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575742, encodeId=8e405e57422e, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享：一审半年意见中肯接受后1月出proof见刊超快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a83b1569848, createdName=36410008, createdTime=Mon Sep 02 21:06:00 CST 2019, time=2019-09-02, status=1, ipAttribution=)]
    2021-12-27 桑晒麦拉

    摘要和HIGHLIGHTS的区别？

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2271609, encodeId=b77822e1609c1, content=11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60209766606, createdName=ms1000000753909589, createdTime=Tue Jul 01 15:19:43 CST 2025, time=2025-07-01, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1219217, encodeId=9458121921e5d, content=想问一下，这个回复审稿人意见是在网站提交还是回复邮件呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60115590202, createdName=Sci中中中中中中, createdTime=Thu May 12 23:55:19 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2224846, encodeId=19a72224846e1, content=审稿速度:6.0 | 投稿命中率:75.0<br>偏重的研究方向：III期研究;肺癌;protocol<br>经验分享：III期研究的protocol还是容易接收，毕竟可能会带动引用率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220704/1acf1fcc54b540239da4b101eb02ebc4/379539e2ee554698a231b4f45583be89.jpg, createdBy=62942283774, createdName=海参饲养员, createdTime=Mon Sep 09 15:41:35 CST 2024, time=2024-09-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=921523, encodeId=75b8921523d0, content=投稿命中率:50.0<br>经验分享：投稿到接受4个月，接受到见刊2个月。着急的的还是绕道吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200708/e0c0acd4c1714a6e8a657fd5e53d76a4/ab7ebd1a6ae24cbdb95ceb66dff657b5.jpg, createdBy=3dad2459355, createdName=Lambda.w, createdTime=Sat Jan 30 23:41:55 CST 2021, time=2021-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1112948, encodeId=3ae41112948cb, content=摘要一定要描述使用的方法么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:54 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1112947, encodeId=548b111294e83, content=摘要和HIGHLIGHTS的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:54 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917956, encodeId=57b391e9569c, content=这个杂志都没人投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7ad5420475, createdName=ms9000000350038058, createdTime=Tue Jan 19 09:06:30 CST 2021, time=2021-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575742, encodeId=8e405e57422e, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享：一审半年意见中肯接受后1月出proof见刊超快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a83b1569848, createdName=36410008, createdTime=Mon Sep 02 21:06:00 CST 2019, time=2019-09-02, status=1, ipAttribution=)]
    2021-01-19 ms9000000350038058

    这个杂志都没人投吗？

    2

    展开2条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2271609, encodeId=b77822e1609c1, content=11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60209766606, createdName=ms1000000753909589, createdTime=Tue Jul 01 15:19:43 CST 2025, time=2025-07-01, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1219217, encodeId=9458121921e5d, content=想问一下，这个回复审稿人意见是在网站提交还是回复邮件呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60115590202, createdName=Sci中中中中中中, createdTime=Thu May 12 23:55:19 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2224846, encodeId=19a72224846e1, content=审稿速度:6.0 | 投稿命中率:75.0<br>偏重的研究方向：III期研究;肺癌;protocol<br>经验分享：III期研究的protocol还是容易接收，毕竟可能会带动引用率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220704/1acf1fcc54b540239da4b101eb02ebc4/379539e2ee554698a231b4f45583be89.jpg, createdBy=62942283774, createdName=海参饲养员, createdTime=Mon Sep 09 15:41:35 CST 2024, time=2024-09-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=921523, encodeId=75b8921523d0, content=投稿命中率:50.0<br>经验分享：投稿到接受4个月，接受到见刊2个月。着急的的还是绕道吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200708/e0c0acd4c1714a6e8a657fd5e53d76a4/ab7ebd1a6ae24cbdb95ceb66dff657b5.jpg, createdBy=3dad2459355, createdName=Lambda.w, createdTime=Sat Jan 30 23:41:55 CST 2021, time=2021-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1112948, encodeId=3ae41112948cb, content=摘要一定要描述使用的方法么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:54 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1112947, encodeId=548b111294e83, content=摘要和HIGHLIGHTS的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:54 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917956, encodeId=57b391e9569c, content=这个杂志都没人投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7ad5420475, createdName=ms9000000350038058, createdTime=Tue Jan 19 09:06:30 CST 2021, time=2021-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575742, encodeId=8e405e57422e, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享：一审半年意见中肯接受后1月出proof见刊超快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a83b1569848, createdName=36410008, createdTime=Mon Sep 02 21:06:00 CST 2019, time=2019-09-02, status=1, ipAttribution=)]
    2019-09-02 36410008

    审稿速度:6.0 | 投稿命中率:50.0
    经验分享：一审半年意见中肯接受后1月出proof见刊超快

    0

共23条页码: 1/3页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分